Skip to main content
Fig. 3 | EJNMMI Research

Fig. 3

From: Identification of EGFR mutation status in male patients with non-small-cell lung cancer: role of 18F-FDG PET/CT and serum tumor markers CYFRA21-1 and SCC-Ag

Fig. 3

Representative PET/CT images of male patients with EGFR mutation and EGFR wild-type. A–D A 54-year-old male patients with lung ADC and normal concentrations of serum CYFRA21-1 (0.7 ng/mL) and SCC-Ag (0.58 ng/mL). Three-dimensional maximum intensity projection (3-D MIP) PET images (A), axial CT (B), PET (C), and fusion PET/CT images (D) showed a mild increase in 18F-FDG uptake of primary lesion (SUVmax 6.09) in the right upper lung (arrows). E–H A 63-year-old male patients with lung ADC and increased concentrations of serum CYFRA21-1 (10.97 ng/mL) and SCC-Ag (4.12 ng/mL). 3-D MIP PET images (A), axial CT (B), PET (C), and fusion PET/CT images (D) showed a significantly increase in 18F-FDG uptake of primary lesion (SUVmax 14.75) in the left upper lung (arrows)

Back to article page